Balance Sheet Data

Akebia Therapeutics, Inc. (AKBA)

$0.2933

-0.01 (-2.23%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 317.79321.64147.69268.69149.80252.18276.42302.99332.12364.05
Total Cash (%)
Account Receivables 34.2216.6738.8626.8550.8733.6036.8340.3744.2548.51
Account Receivables (%)
Inventories -114.24116.3561.0238.1975.0782.2990.2098.87108.38
Inventories (%)
Accounts Payable 742.8039.2241.3133.5930.8833.8537.1040.6744.58
Accounts Payable (%)
Capital Expenditure -1.62-1.61-6.65-0.32-0.06-1.78-1.95-2.14-2.35-2.57
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.